1)Oyama T, Ichimura K, Suzuki R, et al. Senile EBV+B-cell lymphoproliferative disorders : a clinicopathologic study of 22 patients. Am J Surg Pathol 27 : 16-26, 2003
2)Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. IARC Press, Lyon, 2008
3)Shimoyama Y, Yamamoto K, Asano N, et al. Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders : special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci 99 : 1085-1091, 2008
4)Oyama T, Yamamoto K, Asano N, et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group : A study of 96 patients. Clin Cancer Res 13 : 5124-5132, 2007
5)佐野量造.胃疾患の臨床病理.医学書院,pp 257-283,1974
6)Yoshino T, Nakamura S, Matsuno Y, et al. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma. Cancer Sci 97 : 163-166, 2006
7)Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346 : 235-242, 2002
8)Tanaka T, Shimada K, Yamamoto K, et al. Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era : a multicenter study of 95 patients in Japan. Ann Hematol 91 : 383-390, 2012